The groundbreaking treatment of the medication represents a exciting breakthrough in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide targets two pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide591403.widblog.com/96924857/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment